🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD

Recruitingn/aAges 18 Years - anyAllUniversity of Maryland, Baltimore
NCT04946721 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Evaluate and study the immunologic changes to the ocular surface in cancer patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patients (≥ 18 years of age) who visit the Eye clinic either in the UMGCCC within the UMD Hospital or the UMD Faculty Physicians Ophthalmology Practice at the UMD Professional Building or satellite locations for initial visits or established visits. * The patient must be able to understand and sign and date the informed consent form approved by the IRB. Exclusion Criteria: * Vulnerable populations: neonates, children, prisoners, institutionalized individuals. * Inability or refusal to provide informed consent. * History of ocular surgery (except refractive surgery or cataract surgery)
💊

What it tests

  • The standard care exam and biological specimens' collection
📍

Where

1 site
Geenebaum Cancer Center, University of Maryland Medical Center
Baltimore, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy